| Literature DB >> 33923569 |
Mònica Pons1, Alexa Núñez2,3, Cristina Esquinas2,3, María Torres-Durán4, Juan Luis Rodríguez-Hermosa5, Myriam Calle5, Ramón Tubio-Pérez4, Irene Belmonte2, Francisco Rodríguez-Frías6,7, Esther Rodríguez2, Joan Genescà1,7, Marc Miravitlles2,3,8, Miriam Barrecheguren2.
Abstract
Screening of liver disease in alpha-1 antitrypsin deficiency (AATD) is usually carried out with liver enzymes, with low sensitivity. We conducted a multicenter cross-sectional study aiming to describe the utility of transient elastography for the identification of liver disease in patients with AATD. A total of 148 AATD patients were included. Among these, 54.7% were Pi*ZZ and 45.3% were heterozygous for the Z allele. Between 4.9% and 16.5% of patients had abnormal liver enzymes, without differences among genotypes. Liver stiffness measurement (LSM) was significantly higher in Pi*ZZ individuals than in heterozygous Z (5.6 vs. 4.6 kPa; p = 0.001). In total, in 8 (5%) individuals LSM was >7.5 kPa, considered significant liver fibrosis, and ≥10 kPa in 3 (1.9%) all being Pi*ZZ. Elevated liver enzymes were more frequently observed in patients with LSM > 7.5 kPa, but in 5 out of 8 of these patients all liver enzymes were within normal range. In patients with AATD, the presence of abnormal liver enzymes is frequent; however, most of these patients do not present significant liver fibrosis. Transient elastography can help to identify patients with liver fibrosis even with normal liver enzymes and should be performed in all Z-allele carriers to screen for liver disease.Entities:
Keywords: alpha1-antitrypsin deficiency; liver disease; transient elastography
Year: 2021 PMID: 33923569 DOI: 10.3390/jcm10081724
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241